Short Interest in iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Expands By 133.6%

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) saw a significant increase in short interest in the month of January. As of January 15th, there was short interest totaling 3,170 shares, an increase of 133.6% from the December 31st total of 1,357 shares. Currently, 0.2% of the shares of the company are short sold. Based on an average daily volume of 18,112 shares, the days-to-cover ratio is currently 0.2 days. Based on an average daily volume of 18,112 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.2% of the shares of the company are short sold.

iShares LifePath Target Date 2045 ETF Trading Down 0.7%

Shares of NYSEARCA ITDE traded down $0.28 during midday trading on Friday, reaching $37.20. 20,729 shares of the company were exchanged, compared to its average volume of 17,001. The stock has a market cap of $58.03 million, a P/E ratio of 20.03 and a beta of 0.82. iShares LifePath Target Date 2045 ETF has a 1 year low of $27.42 and a 1 year high of $37.64. The stock has a fifty day simple moving average of $36.73 and a 200 day simple moving average of $35.83.

Institutional Investors Weigh In On iShares LifePath Target Date 2045 ETF

Hedge funds have recently modified their holdings of the stock. Susquehanna International Group LLP increased its holdings in iShares LifePath Target Date 2045 ETF by 38.4% during the 3rd quarter. Susquehanna International Group LLP now owns 9,001 shares of the company’s stock valued at $323,000 after acquiring an additional 2,496 shares in the last quarter. Sunbelt Securities Inc. increased its stake in shares of iShares LifePath Target Date 2045 ETF by 2,054.5% during the 3rd quarter. Sunbelt Securities Inc. now owns 2,607 shares of the company’s stock worth $94,000 after purchasing an additional 2,486 shares in the last quarter. Capital Advisors Ltd. LLC acquired a new position in shares of iShares LifePath Target Date 2045 ETF during the 4th quarter worth approximately $53,000. Finally, Geneos Wealth Management Inc. purchased a new stake in iShares LifePath Target Date 2045 ETF in the 1st quarter valued at approximately $34,000.

About iShares LifePath Target Date 2045 ETF

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches. The fund is intended for investors who anticipate retiring around 2045 ITDE was launched on Oct 17, 2023 and is issued by BlackRock.